Ernexa Therapeutics (ERNA) Cash & Equivalents (2010 - 2026)
Ernexa Therapeutics' Cash & Equivalents came in at $5.03 million for Q2 2026, up 16.5% from $4.32 million a year earlier but down 45.3% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics' Cash & Equivalents was $1.88 million, up 9.0% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $1.73 million in FY2024 (-85.2%), $11.67 million in FY2023 (-24.9%), $15.54 million in FY2022 (-8.5%) and $16.99 million in FY2021 (+942.0%).
- The five-year range for quarterly Cash & Equivalents is $1.73 million (Q4 2024) to $24.38 million (Q3 2021).
- Year-over-year, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 15.8% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2021 (growth of 942.0%), and the weakest in Q4 2024 (a decline of 85.2%).
- Business Quant data shows ERNA's Cash & Equivalents at $9.2 million (Q1 2026), $1.88 million (Q4 2025) and $3.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Ernexa Therapeutics | 3.74 Mn | 3.74 Mn | - | 5.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 4.26 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 9.21 Mn |
| Dec 31, 2023 | 11.67 Mn |
| Sep 30, 2023 | 8.65 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 9.49 Mn |
| Dec 31, 2022 | 15.54 Mn |
| Sep 30, 2022 | 13.25 Mn |
| Jun 30, 2022 | 19.41 Mn |
| Mar 31, 2022 | 23.50 Mn |
| Dec 31, 2021 | 16.99 Mn |
| Sep 30, 2021 | 24.38 Mn |
API Access
Ernexa Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();